NUO THERAPEUTICS INC NEW (AURX) SEC filings
AURX SEC filings moved a median of 0.00% by the close. AURX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AURX overview →
39 measured AURX SEC filing events.
Where these AURX SEC filings landedvs 31 measured AURX SEC filing reactions
| Middle 50% of AURX SEC filing reactions | -0.98% to +0.01% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 AURX SEC filing events with a measured close landed between -0.98% and +0.01%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Nuo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Nuo Therapeutics, Inc. For: Aug 17 | SEC filing · Form 8-K | +0.00% | +0.02% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.02% | |
| Form 8-K Nuo Therapeutics, Inc. For: May 29 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Nuo Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | — | — | |
| Form 10-K Nuo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.55% | |
| Form 8-K Nuo Therapeutics, Inc. For: Jan 21 | SEC filing · Form 8-K | +1.27% | +1.27% | |
| Form 8-K Nuo Therapeutics, Inc. For: Dec 16 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Nuo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -15.93% | |
| Form DEF 14A Nuo Therapeutics, Inc. For: Dec 16 | SEC filing · Form DEF | — | +0.00% | |
| Form DEFA14A Nuo Therapeutics, Inc. | SEC filing · Form DEFA14A | — | +0.00% | |
| Form 8-K Nuo Therapeutics, Inc. For: Oct 07 | SEC filing · Form 8-K | +1.46% | +1.46% | |
| Form D Nuo Therapeutics, Inc. | SEC filing · Form D | — | -3.61% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.38% | |
| Form 8-K Nuo Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form EFFECT Nuo Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -1.30% | |
| Form S-3/A Nuo Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | +0.00% | |
| Form S-3 Nuo Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | -2.45% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | +12.11% | |
| Form S-8 Nuo Therapeutics, Inc. | SEC filing · Form S-8 | +5.96% | +5.96% | |
| Form 10-K Nuo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form NT 10-K Nuo Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form D Nuo Therapeutics, Inc. | SEC filing · Form D | +0.00% | -3.64% | |
| Form 8-K Nuo Therapeutics, Inc. For: Sep 18 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.04% | |
| Form 8-K Nuo Therapeutics, Inc. For: Jun 27 | SEC filing · Form 8-K | +0.00% | -0.66% | |
| Form 8-K Nuo Therapeutics, Inc. For: Jun 07 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form D Nuo Therapeutics, Inc. | SEC filing · Form D | — | +0.00% | |
| Form 8-K Nuo Therapeutics, Inc. For: May 17 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Nuo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Nuo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K Nuo Therapeutics, Inc. For: Apr 16 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-K Nuo Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | — | — | |
| Form D Nuo Therapeutics, Inc. | SEC filing · Form D | — | -23.39% | |
| Form 8-K Nuo Therapeutics, Inc. For: Dec 18 | SEC filing · Form 8-K | -0.89% | +9.09% | |
| Form 10-Q Nuo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.02% | -5.45% | |
| Form NT 10-Q Nuo Therapeutics, Inc. For: Sep 30 | SEC filing · Form NT | +0.00% | +0.00% |
Keep exploring
More AURX: earnings → · analyst actions → · AURX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Regen Biopharma, Inc. Common (RGBP) | 85 | 0.00% | 36% |
| UCB SA UNSP/ADR (UCBJY) | 85 | +0.00% | 51% |
| Eloxx Pharmaceuticals, Inc. (ELOX) | 84 | 0.00% | 14% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.